Axsome Therapeutics
AXSM
AXSM
176 hedge funds and large institutions have $1.51B invested in Axsome Therapeutics in 2021 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 67 increasing their positions, 50 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
4% less funds holding
Funds holding: 184 → 176 (-8)
23% less first-time investments, than exits
New positions opened: 24 | Existing positions closed: 31
53% less call options, than puts
Call options by funds: $28.4M | Put options by funds: $60.4M
Holders
176
Holding in Top 10
3
Calls
$28.4M
Puts
$60.4M
Top Buyers
| 1 | +$37.4M | |
| 2 | +$23.7M | |
| 3 | +$11.8M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$10.8M |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
+$10.8M |
Top Sellers
| 1 | -$40.4M | |
| 2 | -$13.4M | |
| 3 | -$12M | |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$11.3M |
| 5 |
Norges Bank
Oslo,
Norway
|
-$9.83M |